Le marché de la gestion des accidents vasculaires cérébraux devrait passer de 33,48 milliards de dollars américains en 2021 à 55,37 milliards de dollars américains. milliards d’ici 2028 ; il devrait croître à un TCAC de 7,5 % entre 2022 et 2028.
L'incidence croissante des maladies chroniques, notamment l'hypertension, l'hyperlipidémie et le diabète, a contribué à la croissance du marché de la gestion des accidents vasculaires cérébraux. L'hypertension est le principal facteur de risque d'accident vasculaire cérébral, car une pression artérielle supérieure à 140/90 mmHg peut endommager les vaisseaux sanguins qui irriguent le cerveau. De plus, le diabète est également une cause majeure d’accident vasculaire cérébral. Selon l’American Stroke Association, les personnes atteintes de diabète ont deux fois plus de chances de subir un accident vasculaire cérébral et peuvent également être témoins d’un accident vasculaire cérébral précoce. De plus, toutes les deux minutes, un adulte diabétique est hospitalisé en raison d’un accident vasculaire cérébral aux États-Unis, selon les mêmes données. En conséquence, les leaders du marché s'efforcent de développer des traitements innovants contre les accidents vasculaires cérébraux, et une grande variété de nouveaux médicaments et dispositifs sont à l'étude pour le traitement et le diagnostic de tous les principaux types d'accidents vasculaires cérébraux, et nombre d'entre eux devraient être approuvés dans le futur. futur proche. Par exemple, en septembre 2020, Johnson & Johnson a annoncé le lancement de Cerenovus Stroke Solutions, qui se compose de trois appareils pouvant aider les médecins à éliminer les caillots. De plus, en août 2021, MicroTransponder Inc. a reçu l'approbation de la FDA pour le système Vivistim, un système de réadaptation après un accident vasculaire cérébral unique en son genre, pour le traitement des déficits moteurs modérés à sévères des membres supérieurs associés à un accident vasculaire cérébral ischémique chronique. >
DYNAMIQUE DU MARCHÉ
< span>La croissance du marché de la gestion des accidents vasculaires cérébraux est principalement attribuée à la prévalence croissante des troubles chroniques, aux progrès technologiques en matière de diagnostic et de diagnostic. traitement des accidents vasculaires cérébraux, augmentation continue du nombre de fumeurs et augmentation de la population gériatrique. Cependant, la lenteur de l'approbation des médicaments et les coûts énormes associés aux procédures impliquées dans le traitement et le diagnostic des accidents vasculaires cérébraux entravent la croissance du marché.
ÉTENDUE DU MARCHÉ
L'analyse du marché mondial de la gestion des accidents vasculaires cérébraux jusqu'en 2028" Le rapport vise à fournir un aperçu du marché de la gestion des accidents vasculaires cérébraux avec une segmentation détaillée du marché. Le rapport fournit des statistiques clés du marché basées sur les performances des principaux acteurs. Il présente également les principales tendances et opportunités du marché.
Informations stratégiques
SEGMENTATION DU MARCHÉ
Le marché mondial de la gestion des accidents vasculaires cérébraux est divisé en types et en applications. En fonction du type, le marché est divisé en diagnostic et thérapeutique. En fonction des applications, le marché est divisé en AVC ischémique et AVC hémorragique.
CADRE RÉGIONAL
Le marché mondial de la gestion des accidents vasculaires cérébraux est segmenté en cinq grandes régions : Amérique du Nord, Europe, Asie-Pacifique, Moyen-Orient et Amérique du Nord. Afrique et Afrique du Sud et Amérique centrale. Le rapport couvre l'analyse et les prévisions de 18 pays à travers le monde ainsi que les tendances et opportunités prévalant dans la région.
L'Amérique du Nord a dominé le marché de la gestion des accidents vasculaires cérébraux avec une part d'environ 37 % en 2021. La croissance du marché dans la région est principalement attribuée à la présence d'une énorme population souffrant de troubles chroniques ainsi qu'à la présence d'acteurs de premier plan sur le marché. tels que Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Cardinal Health Inc. et General Electric Company. La figure ci-dessous présente la tendance à la croissance des revenus sur le marché nord-américain de la gestion des accidents vasculaires cérébraux :
Source : Analyse des partenaires Insight
Le rapport analyse des facteurs tels que les facteurs déterminants, les contraintes, les opportunités, et les tendances futures qui ont un impact sur le marché de la gestion des accidents vasculaires cérébraux. Il fournit également une analyse PEST exhaustive des facteurs affectant le marché.
IMPACT DE LA PANDÉMIE DE COVID-19
Le La pandémie de COVID-19 a entraîné une demande accrue de médicaments pour la gestion des accidents vasculaires cérébraux tels que l'Alteplase, le Clopidogrel et l'Atorvastatine, à mesure que la prévalence des accidents vasculaires cérébraux a augmenté en raison de la propagation du SRAS-CoV-2. Cela a conduit à un volume élevé de commandes parmi les fabricants de médicaments, ce qui a entraîné un volume de production plus élevé. En conséquence, les bénéfices des produits de divers fabricants de composants pharmaceutiques ont augmenté. Ainsi, l’approvisionnement en composants médicamenteux a augmenté au cours de la phase initiale de la pandémie, stimulant ainsi la croissance du marché mondial de la gestion des accidents vasculaires cérébraux.
La sensibilisation croissante à l'AVC a entraîné une augmentation soudaine des taux de diagnostic de la maladie, ce qui a finalement accru la demande de médicaments ciblant l'AVC tels que le Ticagrelor, l'Alteplase et le Clopidogrel. Les activateurs tissulaires recombinants du plasmogène constituent le traitement le plus efficace de l'accident vasculaire cérébral ischémique et sont actuellement prescrits en première intention. En conséquence, l'approvisionnement en activateurs tissulaires recombinants du plasmogène a augmenté, ce qui renforce le marché de la gestion des accidents vasculaires cérébraux.
ACTEURS DU MARCHÉ
Le Le rapport couvre les développements clés du marché de la gestion des accidents vasculaires cérébraux. Diverses entreprises se concentrent sur des stratégies de croissance organique, telles que les lancements de produits, les approbations de produits, les brevets et les événements. Les stratégies de croissance inorganique telles que les acquisitions, les partenariats et les collaborations ont encouragé l’expansion des activités et de la clientèle des acteurs du marché. Les acteurs du marché opérant sur le marché de la gestion des accidents vasculaires cérébraux devraient connaître des opportunités de croissance lucratives dans les années à venir avec la demande croissante de traitements contre les accidents vasculaires cérébraux.
Le rapport comprend également les profils des principales sociétés de gestion des accidents vasculaires cérébraux, ainsi que leur analyse SWOT et leurs stratégies de marché. En outre, le rapport se concentre sur les principaux acteurs du secteur avec des informations telles que les profils d’entreprise, les composants et services proposés, les informations financières des trois dernières années et les développements clés des cinq dernières années. La liste de quelques entreprises engagées sur le marché de la gestion des accidents vasculaires cérébraux est mentionnée ci-dessous :
- •Laboratoires Abbott•B Braun Melsungen AG•Boston Scientific Corporation•Bristol Myers Squibb Co.•Cardinal Health Inc.•General Electric Company•Glaxosmithkline Plc•Medtronic Plc•Merck And Co. Inc.•Siemens AG.
L'équipe de recherche et d'analyse dédiée d'Insight Partner est composée de professionnels expérimentés possédant une expertise statistique avancée et propose diverses options de personnalisation dans l'étude actuelle.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. Abbott Laboratories
2. B Braun Melsungen AG
3. Boston Scientific Corp.
4. Bristol-Myers Squibb
5. Cardinal Health
6. Medtronic Plc.
7. GlaxoSmithKline Plc.
8. GE Healthcare
9. Merck
10. Koninklijke Philips N.V.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography